Author:
Tamborino Giulia,Nonnekens Julie,Struelens Lara,De Saint-Hubert Marijke,Verburg Frederik A.,Konijnenberg Mark W.
Subject
General Physics and Astronomy,Radiology, Nuclear Medicine and imaging,General Medicine,Biophysics
Reference49 articles.
1. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE in the phase III netter-1 trial;Strosberg;J Clin Oncol,2018
2. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs;Kwekkeboom;J Nucl Med,2005
3. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides;O’Donoghue;J Nucl Med,1995
4. Tumor response after [90Y-DOTA0, Tyr3]-octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size;De Jong;J Nucl Med,2001
5. [177Lu-DOTA0, Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy;De Jong;Int J Cancer,2001
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献